| Absorption |
| Blood-Brain Barrier | BBB- | 0.9490 |
| Human Intestinal Absorption | HIA+ | 0.9919 |
| Caco-2 Permeability | Caco2+ | 0.7513 |
| P-glycoprotein Substrate | Substrate | 0.8137 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7791 |
| Non-inhibitor | 0.8534 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6647 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4936 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8217 |
| CYP450 2D6 Substrate | Non-substrate | 0.8575 |
| CYP450 3A4 Substrate | Non-substrate | 0.7024 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9189 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8878 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8643 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8427 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8899 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5197 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7880 |
| Non-inhibitor | 0.7518 |
| AMES Toxicity | AMES toxic | 0.9107 |
| Carcinogens | Non-carcinogens | 0.8649 |
| Fish Toxicity | High FHMT | 0.9979 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9594 |
| Honey Bee Toxicity | Low HBT | 0.8959 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.8000 |
| Carcinogenicity (Three-class) | Non-required | 0.5950 |